首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells
【24h】

Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells

机译:新型人类组织蛋白酶S抑制剂对人类癌细胞中细胞迁移的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Elevated cathepsin S (Cat S) level is correlated with higher migration ability in tumor cells. This study investigates the inhibitory effect of novel synthetic alpha-ketoamide compounds on cathepsin activity and cancer cell migration. The effect of several alpha-ketoamide compounds on the activity of recombinant cathepsins (Cat S, Cat L and Cat K) was examined. Two highly metastatic cancer cell lines were incubated with three Cat S-specific compounds (6n, 6w and 6r) to analyze their effect on cellular Cat S activity and cell migration. At a 100 nM concentration, compounds 6n, 6r and 6w effectively inhibited Cat S activity. Cat S activity and cell migration were significantly reduced in CL1-3 cells after treatment with either 6n or 6w at 5 mu M. Similar results were also obtained when A2058 cells were treated with 6n. These results highlight the therapeutic potential of alpha-ketoamide compounds, especially 6n and 6w, to prevent or delay cancer metastasis.
机译:组织蛋白酶S(Cat S)水平升高与肿瘤细胞中更高的迁移能力相关。这项研究调查了新型合成α-酮酰胺化合物对组织蛋白酶活性和癌细胞迁移的抑制作用。检查了几种α-酮酰胺化合物对重组组织蛋白酶(Cat S,Cat L和Cat K)活性的影响。将两种高度转移性癌细胞系与三种Cat S特异性化合物(6n,6w和6r)孵育,以分析它们对细胞Cat S活性和细胞迁移的影响。在100 nM浓度下,化合物6n,6r和6w有效抑制Cat S活性。用5nM的6n或6w处理后,CL1-3细胞的Cat S活性和细胞迁移显着降低。当用6n处理A2058细胞时,也获得了相似的结果。这些结果突出了α-酮酰胺化合物(特别是6n和6w)在预防或延迟癌症转移方面的治疗潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号